×

BRIEF-Anacor Pharmaceuticals says GSK has discontinued development of urinary tract infection drug

Oct 5 (Reuters) - Anacor Pharmaceuticals Inc :

* Announces that GSK has discontinued clinical development of gsk2251052

* Says Anacor and GSK are currently working together to transition gsk2251052

back to Anacor

((Bangalore Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

((For more news, please click here ))